NAFLD as a risk factor for HCC: new rules of engagement? Ryota MasuzakiSeth J. KarpMasao Omata Editorial Open access 05 May 2016 Pages: 533 - 534
iNKT cells in chronic HBV: a balancing act Maike HofmannRobert Thimme Editorial 24 May 2016 Pages: 535 - 537
New therapeutic targets in alcoholic hepatitis Diana ArseneOmar FarooqRamon Bataller Review Article 12 April 2016 Pages: 538 - 552
Biliary complications in right lobe living donor liver transplantation Kenneth S. H. ChokChung Mau Lo Review Article 01 March 2016 Pages: 553 - 558
HBV culture and infectious systems C. Nelson HayesKazuaki Chayama Review Article 02 March 2016 Pages: 559 - 566
Hepatitis B virus receptors and molecular drug targets Eloi R. VerrierChe C. ColpittsThomas F. Baumert Review Article 15 March 2016 Pages: 567 - 573
Prevention of hepatitis B virus-associated liver diseases by antiviral therapy Akinobu TawadaTatsuo KandaOsamu Yokosuka Review Article 29 March 2016 Pages: 574 - 593
The dynamic changes of circulating invariant natural killer T cells during chronic hepatitis B virus infection Man LiZhen-Hua ZhouYue-Qiu Gao Original Article 26 February 2016 Pages: 594 - 601
Will a second biopsy sample affect treatment decisions in patients with chronic hepatitis B? Fuat Ekizİlhami YukselOsman Yuksel Original Article 28 September 2015 Pages: 602 - 605
Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis Xueyuan NianZhihui XuDongping Xu Original Article 16 March 2016 Pages: 606 - 615
Examining the clinical course of genotype 1 chronic hepatitis C patients treated with the cosmos regimen: including patients with advanced liver disease and East Asian ancestry Marina RoytmanResham RamkissoonNaoky Tsai Original Article 30 March 2016 Pages: 616 - 623
Is response guided therapy dead? Low cure rates in patients with detectable hepatitis C virus at week 4 of treatment Karla ThorntonPaulina DemingSanjeev Arora Original Article 20 April 2016 Pages: 624 - 631
Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis Bashar MohamadVaishal ShahNaim Alkhouri Original Article 11 November 2015 Pages: 632 - 639
An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients Yong-kang LiuBao-shan HuLi-gong Lu Original Article 26 April 2016 Pages: 640 - 646
Impact of circulating miR-122 for histological features and hepatocellular carcinoma of nonalcoholic fatty liver disease in Japan Norio AkutaYusuke KawamuraHiromitsu Kumada Original Article 13 April 2016 Pages: 647 - 656
Selection and outcome of the potential live liver donor Viniyendra PamechaShyam Sunder MahansariaShiv Kumar Sarin Original Article 17 March 2016 Pages: 657 - 664
Role of cytokine gene polymorphisms in acute and chronic kidney disease following liver transplantation Hideya KameiYasuharu OnishiNobuyuki Hamajima Original Article 22 March 2016 Pages: 665 - 672
Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients Nwe Ni ThanDoreen Koay Siew ChingYe Htun Oo Original Article Open access 21 April 2016 Pages: 673 - 679